Toggle Main Menu Toggle Search

Open Access padlockePrints

Anti-TNFα Therapy Modulates the Phenotype of Peripheral Blood CD4+ T Cells in Patients with Posterior Segment Intraocular Inflammation

Lookup NU author(s): Professor John IsaacsORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

PURPOSE. Posterior segment intraocular inflammation (PSII) is a putative Th1 CD4+ cell mediated autoimmune disorder. In experimental autoimmune uveoretinitis, neutralization of tumor necrosis factor (TNF)-α induces suppression of Th1 cells, macrophage activation, and target organ damage. Previous studies implicated an efficacy of anti-TNFα therapies in patients with PSII. This study investigated the immunomodulatory effect of anti-TNFα therapy to find predictors of effective immunosuppression in PSII. METHODS. Fifteen patients with PSII refractory to conventional immunosuppressive therapy received a single infusion of a recombinant protein generated by fusing the p55 TNFα receptor with human IgG1. During 17 treatment periods, visual acuity (logarithm of the minimum angle of resolution [log-MAR]) was monitored as a response criterion. Phenotype markers of CD4 + T cells were analyzed before and 2, 4, and 12 weeks after therapy. Expression of intracellular cytokines (interferon [IFN]-γ, interleukin [IL]-10, and TNFα and Th1/Th2-specific chemokine receptors (CXCR3, CCR4, and CCR5) on peripheral blood CD4+ T cells was determined using flow cytometry. RESULTS. The fraction of IL-10-expressing CD4+ T cells was increased during 12 of 17 treatment periods within 2 weeks after treatment. During eight treatment periods, this increase was associated with an improvement of visual acuity of at least 0.2 logMAR within 4 weeks (P = 0.029). The ratio between IL-10- and IFNγ-expressing CD4+ T cells was significantly increased 2 weeks after therapy (P = 0.015). There was no significant change of CXCR3, CCR4, or CCR5 expression. CONCLUSIONS. Neutralizing TNFα activity in PSII increases the fraction of peripheral blood CD4+ T cells expressing IL-10, which correlates with a recovery of visual function.


Publication metadata

Author(s): Greiner K, Murphy CC, Willermain F, Duncan L, Plskova J, Hale G, Isaacs JD, Forrester JV, Dick AD

Publication type: Article

Publication status: Published

Journal: Investigative Ophthalmology and Visual Science

Year: 2004

Volume: 45

Issue: 1

Pages: 170-176

ISSN (print): 0146-0404

ISSN (electronic): 1552-5783

Publisher: Association for Research in Vision and Ophthalmology

URL: http://dx.doi.org/10.1167/iovs.03-0659

DOI: 10.1167/iovs.03-0659


Altmetrics

Altmetrics provided by Altmetric


Share